| 000 | 01581 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250515160812.0 | ||
| 264 | 0 | _c20090511 | |
| 008 | 200905s 0 0 eng d | ||
| 022 | _a1742-1241 | ||
| 024 | 7 |
_a10.1111/j.1742-1241.2008.01988.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPertel, P E | |
| 245 | 0 | 0 |
_aThe efficacy and safety of daptomycin vs. vancomycin for the treatment of cellulitis and erysipelas. _h[electronic resource] |
| 260 |
_bInternational journal of clinical practice _cMar 2009 |
||
| 300 |
_a368-75 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aCellulitis _xdrug therapy |
| 650 | 0 | 4 |
_aDaptomycin _xadministration & dosage |
| 650 | 0 | 4 |
_aErysipelas _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aVancomycin _xadministration & dosage |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aEisenstein, B I | |
| 700 | 1 | _aLink, A S | |
| 700 | 1 | _aDonfrid, B | |
| 700 | 1 | _aBiermann, E J A | |
| 700 | 1 | _aBernardo, P | |
| 700 | 1 | _aMartone, W J | |
| 773 | 0 |
_tInternational journal of clinical practice _gvol. 63 _gno. 3 _gp. 368-75 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1742-1241.2008.01988.x _zAvailable from publisher's website |
| 999 |
_c18665500 _d18665500 |
||